Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics
The Blue Biotechnology and Ecotoxicology Culture Collection (LEGE-CC) holds a vast number of cyanobacteria whose chemical richness is still largely unknown. To expedite its bioactivity screening we developed a natural products library. Sixty strains and four environmental samples were chromatographe...
Guardado en:
Autores principales: | , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7bb6d77e420544109d44cc5b253900c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:7bb6d77e420544109d44cc5b253900c5 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:7bb6d77e420544109d44cc5b253900c52021-11-25T18:12:57ZUncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics10.3390/md191106331660-3397https://doaj.org/article/7bb6d77e420544109d44cc5b253900c52021-11-01T00:00:00Zhttps://www.mdpi.com/1660-3397/19/11/633https://doaj.org/toc/1660-3397The Blue Biotechnology and Ecotoxicology Culture Collection (LEGE-CC) holds a vast number of cyanobacteria whose chemical richness is still largely unknown. To expedite its bioactivity screening we developed a natural products library. Sixty strains and four environmental samples were chromatographed, using a semiautomatic HPLC system, yielding 512 fractions that were tested for their cytotoxic activity against 2D and 3D models of human colon carcinoma (HCT 116), and non-cancerous cell line hCMEC/D3. Six fractions showed high cytotoxicity against 2D and 3D cell models (group A), and six other fractions were selected by their effects on 3D cells (group B). The metabolome of each group was organized and characterized using the MolNetEnhancer workflow, and its processing with MetaboAnalyst allowed discrimination of the mass features with the highest fold change, and thus the ones that might be bioactive. Of those, mass features without precedented identification were mostly found in group A, indicating seven possible novel bioactive molecules, alongside in silico putative annotation of five cytotoxic compounds. Manual dereplication of group B tentatively identified nine pheophytin and pheophorbide derivatives. Our approach enabled the selection of 7 out of 60 cyanobacterial strains for anticancer drug discovery, providing new data concerning the chemical composition of these cyanobacteria.Leonor FerreiraJoão MoraisMarco PretoRaquel SilvaRalph UrbatzkaVitor VasconcelosMariana ReisMDPI AGarticlenatural products librarycyanobacteriacytotoxicity3D spheroidsuntargeted metabolomicsMetaboAnalystBiology (General)QH301-705.5ENMarine Drugs, Vol 19, Iss 633, p 633 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
natural products library cyanobacteria cytotoxicity 3D spheroids untargeted metabolomics MetaboAnalyst Biology (General) QH301-705.5 |
spellingShingle |
natural products library cyanobacteria cytotoxicity 3D spheroids untargeted metabolomics MetaboAnalyst Biology (General) QH301-705.5 Leonor Ferreira João Morais Marco Preto Raquel Silva Ralph Urbatzka Vitor Vasconcelos Mariana Reis Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics |
description |
The Blue Biotechnology and Ecotoxicology Culture Collection (LEGE-CC) holds a vast number of cyanobacteria whose chemical richness is still largely unknown. To expedite its bioactivity screening we developed a natural products library. Sixty strains and four environmental samples were chromatographed, using a semiautomatic HPLC system, yielding 512 fractions that were tested for their cytotoxic activity against 2D and 3D models of human colon carcinoma (HCT 116), and non-cancerous cell line hCMEC/D3. Six fractions showed high cytotoxicity against 2D and 3D cell models (group A), and six other fractions were selected by their effects on 3D cells (group B). The metabolome of each group was organized and characterized using the MolNetEnhancer workflow, and its processing with MetaboAnalyst allowed discrimination of the mass features with the highest fold change, and thus the ones that might be bioactive. Of those, mass features without precedented identification were mostly found in group A, indicating seven possible novel bioactive molecules, alongside in silico putative annotation of five cytotoxic compounds. Manual dereplication of group B tentatively identified nine pheophytin and pheophorbide derivatives. Our approach enabled the selection of 7 out of 60 cyanobacterial strains for anticancer drug discovery, providing new data concerning the chemical composition of these cyanobacteria. |
format |
article |
author |
Leonor Ferreira João Morais Marco Preto Raquel Silva Ralph Urbatzka Vitor Vasconcelos Mariana Reis |
author_facet |
Leonor Ferreira João Morais Marco Preto Raquel Silva Ralph Urbatzka Vitor Vasconcelos Mariana Reis |
author_sort |
Leonor Ferreira |
title |
Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics |
title_short |
Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics |
title_full |
Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics |
title_fullStr |
Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics |
title_full_unstemmed |
Uncovering the Bioactive Potential of a Cyanobacterial Natural Products Library Aided by Untargeted Metabolomics |
title_sort |
uncovering the bioactive potential of a cyanobacterial natural products library aided by untargeted metabolomics |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/7bb6d77e420544109d44cc5b253900c5 |
work_keys_str_mv |
AT leonorferreira uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics AT joaomorais uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics AT marcopreto uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics AT raquelsilva uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics AT ralphurbatzka uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics AT vitorvasconcelos uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics AT marianareis uncoveringthebioactivepotentialofacyanobacterialnaturalproductslibraryaidedbyuntargetedmetabolomics |
_version_ |
1718411505022533632 |